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Aqueous Two-Phase System Patterning of Microbubbles: 
Localized Induction of Apoptosis in Sonoporated Cells Ultrasound-driven microbubbles produce mechanical forces that can disrupt 
cell membranes (sonoporation). However, it is diffi cult to control microbubble 
location with respect to cells. This lack of control leads to low sonoporation 
effi ciencies and variable outcomes. In this study, aqueous two-phase system 
(ATPS) droplets are used to localize microbubbles in select micro-regions at 
the surface of living cells. This is achieved by stably partitioning microbub-
bles in dextran (DEX) droplets, deposited on living adherent cells in medium 
containing polyethylene glycol (PEG). The interfacial energy at the PEG-DEX 
interface overcomes microbubble buoyancy and prevents microbubbles from 
fl oating away from the cells. Spreading of the small DEX droplets retains 
microbubbles at the cell surface in defi ned lateral positions without the need 
for antibody or cell-binding ligand conjugation. The patterned microbubbles 
are activated on a cell monolayer exposed to a broadly applied ultrasound 
fi eld (center frequency 1.25 MHz, active element diameter 0.6 cm, pulse 
duration 8  μ s or 30 s). This system enables effi cient testing of different 
ultrasound conditions for their effects on sonoporation-mediated membrane 
disruption and cell viability. Regions of cells without patterned microbubbles 
show no injury or membrane disruption. In microbubble patterned regions, 
8  μ s ultrasound pulses (0.2-0.6 MPa) produce cell death that is primarily 
apoptotic. Ultrasound-induced apoptosis increases with higher extracellular 
calcium concentrations, with cells displaying all of the hallmarks of apoptosis 
including annexinV labeling, loss of mitochondrial membrane potential, cas-
pase activation and changes in nuclear morphology.  1. Introduction 
 Cell and biomolecule patterning is used in tissue engineering 
and biomedical research for high-throughput cell assays and 
investigation of interactions among populations of cells. Pat-
terning is typically achieved by depositing materials on a sub-
strate prior to cell attachment (e.g., microcontact printing, © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheiwileyonlinelibrary.com
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izing reagents over a preexisting cell mon-
olayer (e.g., laminar fl ow patterning [ 2 , 3 ] or 
microelectromechanical system (MEMS)-
based culture platforms [ 4 , 5 ] ). However, 
these strategies can be diffi cult to trans-
late to wide-spread use in the life sciences 
because they often use custom fabricated 
devices that require a high degree of user 
expertise to operate. 
 Recently, we developed a microdevice-
free technology that can pattern cells 
and deliver biomolecular treatments 
to specifi c populations of cells. This 
user-friendly, cell-compatible approach 
involves confi nement of biomolecules 
within the dextran (DEX) phase of a poly-
ethylene glycol (PEG)/DEX aqueous two-
phase system (ATPS). [ 6 , 7 ] ATPS printing is 
non-destructive to cells, easy to perform, 
inexpensive and can be used with many 
types of cell culture systems. In addi-
tion, ATPSs can be used to directly pat-
tern particles of various sizes including 
viruses, bacteria and mammalian cells, 
all of which are not easily patterned with 
other methods. [ 7–10 ] 
 We predicted that lipid coated, gas core 
microbubbles could also be patterned 
using ATPS. When driven by ultrasound, microbubbles rapidly expand and contract, and/or collapse, pro-
ducing submicron or micron scale mechanical effects including 
high speed fl uidic microjets, shear stress, shock waves and 
direct deformation of cell membranes. [ 11–15 ] These mechanical 
forces can create pores in cell membranes, that can be tran-
sient or irreversible depending on the ultrasound parameters. 
The membrane disruption mediated by ultrasound excitation of 
microbubbles, referred to as sonoporation, has found applica-
tions both in vitro and in vivo, emerging as a valuable tool for 
transiently disrupting cell membranes to allow entry of mem-
brane impermeable exogenous agents into cells or to induce 
cell death. [ 14 , 16 , 17 ] This technique is particularly advantageous 
because ultrasound application is noninvasive. However, sonop-
oration is limited by a lack of control over microbubble loca-
tion with respect to cells, often resulting in variable treatment 
outcomes and suboptimal effi ciencies. Gas-fi lled microbubbles 
easily fl oat to the surface of the cell culture medium in vitro, far 
from where they can exert their effects on adherent cells. Even m Adv. Funct. Mater. 2013, 23, 3420–3431
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pended cells, the temporal variation of their spatial distribution 
in the bulk solution caused by buoyancy results in unpredict-
able outcomes, precluding detailed investigation of pore forma-
tion and cell injury/death. 
 In ultrasound molecular imaging, much effort has been 
devoted to developing strategies for decorating the exterior of 
encapsulated microbubbles with antibodies/ligands that target 
them to the surface of cells. [ 18–21 ] Since these targeted microbub-
bles attach to cell membranes, they can also provide the oppor-
tunity to disrupt cell membranes. [ 22–24 ] For in vitro experiments, 
binding of targeted microbubbles to adherent cells is typically 
achieved by applying a small amount of solution containing the 
targeted microbubbles to the cells in a cell culture dish or to 
cells growing within a specialized chamber. In these examples, 
the microbubbles bind to the entire cell monolayer; therefore, 
sonoporation is induced in all cells with bound microbub-
bles. Such systems do not provide the spatial selection that is 
required to target subpopulations of cells within a monolayer. 
Furthermore, expensive antibodies/ligands are needed to attach 
the microbubbles to the cells. 
 In this study, we developed a novel approach to address these 
limitations by spatially patterning microbubbles using ATPSs 
and confi ning them to the surface of cells, where they can 
be subsequently excited by ultrasound. This approach allows 
localization of ultrasound-driven microbubbles to specifi c sites 
within a cell culture system, which cannot be achieved by any 
other currently available method. Furthermore, our system is 
compatible with most types of cell culture substrates including 
standard Petri dishes and well plates made from tissue culture 
plastics. The patterned microbubbles allow both the experi-
mental treatments and the control (where cells within different 
regions are exposed to the same ultrasound condition without 
microbubbles nearby) to be simultaneously performed, in one 
step, in a single cell culture dish. By patterning microbubbles 
at multiple sites, multiple ultrasound conditions can be tested 
within the same culture dish, providing a multiplexed platform 
for effi cient investigation of ultrasound-mediated sonoporation 
and downstream effects on cells, including induction of apop-
tosis. Our approach provides an easy method for targeting cells 
because it does not require expensive antibodies or ligands for 
decorating the microbubbles. 
 2. Results 
 2.1. Microbubble Patterning 
 We achieved microbubble patterning by dispensing droplets of 
DEX containing microbubbles through a glass capillary needle 
onto a cell monolayer immersed in PEG. Prior to dispensing the 
microbubbles, we broke the end of the capillary to prevent clog-
ging and shearing of bubbles during the dispensing process. 
The use of a capillary needle allowed us to dispense droplets of 
DEX ( ∼ 0.05–0.10  μ L) that were much smaller than droplets pro-
duced using a micropipettor (0.5–2.0  μ L) ( Figure  1 A–C). DEX 
has a slightly greater density than PEG, causing the DEX drop-
lets to sink and contact the cell monolayer. Spreading of the © 2013 WILEY-VCH Verlag GAdv. Funct. Mater. 2013, 23, 3420–3431small DEX droplets over the cells confi ned the microbubbles at 
the cell surface (Z-dimension). This method allowed us to place 
multiple, discrete or continuous treatment sites within the 
same monolayer (XY dimensions) without the use of special-
ized fl uidic devices, membrane plates or dish inversion. After 
patterning the DEX droplets, additional PEG was added to the 
dish without disturbing the patterning so that the active element 
at the tip of the ultrasound transducer (which was focused on 
the cells on the dish) was immersed. Application of ultrasound 
was then used to excite the microbubbles and generate cavita-
tion, or rapid expansion and contraction of the microbubbles, 
resulting in bursting or shrinking of the microbubbles near the 
cells (Figure  1 D–F), confi rming that the microbubbles in DEX 
behaved similarly as they do in cell culture medium. [ 25 ] It was 
possible to dispense droplets of DEX containing microbubbles 
in close proximity to one another for multiplexing and to gen-
erate a variety of specialized user-defi ned patterns (Figure  1 G). 
Ultrasound excitation of the patterned microbubbles gener-
ated membrane disruption and induced cell death in discrete 
regions, as indicated by the staining pattern for annexinV 
(apoptosis) and propidium iodide (PI) (membrane disruption) 
in the microbubble patterned regions (Figure  1 H). 
 We found that patterning was dependent on the type of 
microbubbles due to differential partitioning in the ATPS. 
We tested two types of commercially available microbubbles, 
Defi nitylipid coated microbubbles and Targestar-SA microbub-
bles (with and without antibody conjugation), to determine 
their partitioning in the PEG/DEX system ( Figure  2 A). Defi nity 
microbubbles partitioned primarily to the PEG phase and to 
the interface for the phase systems we tested. This occurred 
because the non-polar lipid shells of the Defi nity microbubbles 
were more compatible with PEG. Targestar-SA microbubbles 
partitioned primarily to the interface and to the DEX phase. A 
greater proportion of microbubbles were observed in the DEX 
phase for lower DEX molecular weights (3500 and 10 000 kDa 
DEX), most likely because proteins such as streptavidin display 
stronger partitioning to DEX at low DEX molecular weights. 
This was true regardless of the presence of conjugated antibody. 
Partitioning to the interface was not only dependent on micro-
bubble chemistry and size, but was also caused by buoyancy of 
the microbubbles in DEX. 
 Microbubble partitioning was confi rmed by placing micro-
bubbles directly into DEX and then dispensing DEX/micro-
bubble droplets into a solution of PEG (Figure  2 B). Defi nity 
microbubbles rapidly moved to the interface, with some 
crossing the interface and entering the PEG. In contrast, Targ-
estar-SA microbubbles remained well distributed in the DEX 
droplet. These experiments allowed us to monitor the distribu-
tion of microbubbles in DEX droplets and showed that Targe-
star-SA microbubbles remained in the DEX droplets in spite of 
their buoyancy. 
 We next tested the ability of various DEX/microbubble com-
binations to disrupt cell membranes upon ultrasound appli-
cation in the presence of the cell impermeable dye PI (Figure 
 2 C). As expected, no PI staining was observed with ultrasound 
application to patterned DEX droplets using Defi nity micro-
bubbles, as these microbubbles rapidly escaped from the DEX 
phase and fl oated to the surface of the PEG, where they had no 
effect on the cells. Patterned droplets containing Targestar-SA 3421wileyonlinelibrary.commbH & Co. KGaA, Weinheim
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 Figure  1 .  Patterned sonoporation is achieved by depositing microbubbles on cells in the DEX phase of a PEG/DEX ATPS. A) Microbubbles are dis-
pensed onto cells in PEG using a glass capillary needle. B,C) The ultrasound transducer is used to activate the bubbles which are contained within the 
DEX phase. D-F) High magnifi cation images of a single microbubble in DEX attached to a single cell (as indicated by the black arrows) before, during, 
and after ultrasound application captured with a high speed camera. This bubble was activated upon ultrasound treatment, undergoing rapid expansion 
and contraction, which resulted in bursting/shrinking on the cell, as visualized using ultrafast videomicroscopy. As microbubbles expand and contract 
during ultrasound application at 1.25 MHz, halos appear around the microbubbles due to rapid volume changes (E). After microbubble activation, 
the microbubbles disappear or become smaller in size (F). G) Microbubbles can be patterned with various user-defi ned array geometries, as indicated 
by patterning of a Michigan “M”, visualized with intracellular PI staining after microbubble excitation. H) Apoptosis was selectively induced in the 
microbubble patterned regions treated with ultrasound (0.6 MPa, 8  μ s pulse) as indicated by annexinV (green) and PI (red) staining after ultrasound 
treatment. All images are for non-conjugated Targestar-SA microbubbles. Scale bars are  ∼ 5  μ m in (D–F) and  ∼ 300  μ m in (G) and (H). microbubbles, however, were able to disrupt cell membranes 
allowing entry of PI into cells in the DEX/microbubble-covered 
regions, even without antibody conjugation of the microbub-
bles to the cells. We did not notice a difference in the number 
of PI loaded cells following ultrasound treatment as a function 
of antibody concentration (i.e., with or without anti-CD31 anti-
body which targets HUVECs), indicating that the unattached 
microbubbles had an effect on cells by virtue of their close prox-
imity to the cell surface, as dictated by the small height of the 
DEX droplet. This fi nding is important because it demonstrates 
the ability of micropatterned DEX droplets to spatially confi ne 
the microbubbles to the cell surface for sonoporation without 
the need for coupling to expensive antibodies. 
 For subsequent experiments we chose to use the DEX 
10 000 kDa/PEG 35 000 kDa phase system with unconjugated 
Targestar-SA microbubbles, since this formulation displayed 
reasonable partitioning properties, and had polymer concentra-
tions and viscosities low enough for use with cells. In addition, 
DEX 10 000 kDa showed more spreading on cells than DEX 
500 000 kDa, ensuring that bubbles fl oating to the interface 
would still remain in close proximity to the cells. 2 wileyonlinelibrary.com © 2013 WILEY-VCH Verlag 2.2. Sonoporation of Sub-Populations of Cells within a 
Mono layer: Effects of Polymer Concentration, Microbubble 
Concentration and Cell Type 
 We applied our DEX/microbubble patterning system to inves-
tigate cell membrane disruption and death as a function of 
ultrasound pressure, polymer concentration, microbubble con-
centration and cell type. We used PI (applied after ultrasound) 
as a marker for cell membrane disruption and cell death. 
Since microbubbles could be arrayed with various spacing and 
number of treated regions, this allowed us to test multiple 
ultrasound conditions in parallel (e.g., different numbers of 
pulses and pressure amplitudes), essentially multiplexing the 
ultrasound treatment ( Figure  3 A). Without ATPS localization 
(spatial scale of  ∼ 0.75 mm 2 or less with ATPS), this type of mul-
tiplexing would not have been possible, since the ultrasound 
excitation covers a treatment area several times larger than the 
ATPS microbubble patterns. 
 We next tested different polymer concentrations of DEX in 
the 16% PEG 35 000 kDa/DEX 10 000 kDa system. Both the 
dextran and the PEG used in our system are biocompatible  GmbH & Co. KGaA, Weinheim Adv. Funct. Mater. 2013, 23, 3420–3431
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 Figure  2 .  Partitioning of microbubbles. A) The percentage of microbubbles present in DEX, at the PEG/DEX interface and in PEG was calculated for 
various ATPS formulations with different DEX molecular weights. Defi nity microbubbles localized to the interface and the PEG phase, whereas Targe-
star-SA microbubbles localized to the interface and the DEX phase for lower molecular weight of DEX. Bars denote mean  ± SEM. B) Microbubbles that 
were deposited within DEX droplets and tracked by video microscopy confi rmed the results in (A). Defi nity bubble collected at the PEG/DEX interface 
and eventually crossed the interface to enter the PEG phase. Targestar-SA microbubbles were well-retained in DEX. Scale bar  ∼ 60  μ m. C) Droplets of 
DEX containing Defi nity microbubbles could not mediate transmembrane delivery of PI in HUVECs. Droplets with Targestar-SA microbubbles mediated 
PI delivery with high effi ciency in HUVECs, even without antibody targeting. Scale bar  ∼ 300  μ m. and noncytotoxic; therefore, the polymers themselves had little 
to no direct effect on cell apoptosis. Moreover, the intracellular 
cytocompatibility of these polymers has been demonstrated 
using lipofection as a membrane disruption method, as well 
as through numerous studies that have used cell microin-
jection of fl uorophore-conjugated polymers such as dextran 
for cell tracing. For these experiments, a single ultrasound 
pulse was applied (8  μ s duration and 0.4 MPa peak negative 
pressure) to excite the microbubbles. A DEX concentration 
of 16% was optimal for maintaining an even distribution of 
microbubbles on the cells. Solutions of 8% DEX and 4% DEX 
produced clusters of microbubbles on the cells, resulting in 
uneven microbubble distribution, ineffi cient microbubble 
activation and reduced effi ciency of cell membrane disruption 
(Figure  3 B). The clustering effect was likely due to equilibra-
tion of the DEX droplets in PEG, which caused the DEX solu-
tion to decrease dramatically in volume, resulting in micro-
bubble aggregation. 
 Using the 16% PEG 35 000 kDa/16% DEX 10 000 kDa 
system, we tested the effect of microbubble concentration on 
membrane disruption. The highest concentration of micro-
bubbles we tested was  ∼ 0.5  × 10 9 /mL, which was determined 
by the maximum concentration of microbubbles provided © 2013 WILEY-VCH Verlag GmAdv. Funct. Mater. 2013, 23, 3420–3431by the manufacturer ( ∼ 1.0  × 10 9 /mL) and the maximum 
concentration of DEX 10 000 kDa that could be easily pre-
pared (32%) mixed in equal parts (0.5X microbubble con-
dition). We also tested microbubble concentrations that 
were 10-fold and 100-fold lower (0.05X and 0.005X micro-
bubble conditions). The effi ciency of cell membrane disrup-
tion decreased dramatically as microbubble concentration 
decreased (Figure  3 C). 
 It should be noted that the microbubble concentration we 
used ( ∼ 0.5  × 10 9 /mL) was much higher than what is typically 
used for sonoporation. The small volumes of our ATPS drop-
lets made it possible for us to use such high concentration 
of microbubbles in our study. This would be prohibitive in a 
conventional sonoporation experiment due to the cost asso-
ciated with the large amount of this reagent. Although it is 
expected that high bubble concentrations should generate 
the strongest sonoporation effects on cells, we have observed 
interactions among microbubbles (due to the secondary radi-
ation force or Bjerknes force) at high microbubble concentra-
tions. [ 26 , 27 ] This increased level of microbubble-microbubble 
interaction may infl uence their ability to produce direct 
effects on the cells during sonoporation. Thus, attempts to 
use microbubble concentrations much higher than those 3423wileyonlinelibrary.combH & Co. KGaA, Weinheim
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 Figure  3 .  Optimization of ultrasound and microbubble conditions for targeted cell killing. A) Placing DEX droplets in an array allows multiplexed testing 
of ultrasound parameters such as number of pulses (down) and pressure amplitude (across). The array image is a reconstructed mosaic from high 
magnifi cation brightfi eld and PI images. Scale  ∼ 500  μ m. Cell death was minimal at low pressures (0.1 and 0.2 MPa). Multiple low pressure pulses (3 
or 4 pulses) resulted in a slight increase in cell death for the 0.2 MPa ultrasound condition. Pressures of 0.4 and 0.6 MPa resulted in a high proportion 
of cells dying in the patterned areas, with little effect from additional pulses. B) Decreasing the DEX concentration resulted in microbubble aggregation. 
Cell death was markedly reduced at 8% and 4% DEX concentrations. C) The proportion of dead cells decreased with decreasing microbubble concentra-
tions. D) HUVECs were most sensitive to microbubble excitation, but cell death was similar among all the cell types we tested. Control regions without 
microbubbles showed minimal cell death (data compiled for all cell types). Bars in (B–D) denote mean  ± SEM for n  = 3 independent experiments. E) 
Time lapse imaging of microbubble targeted co-cultures of MDA231, NIH 3T3 and HUVECs showed that cell debris was gradually removed over the 
course of several days as the treated regions became repopulated by cells from surrounding untreated areas. Scale  ∼ 60  μ m. used in this study are unlikely to further enhance the effi -
ciency of sonoporation. 
 Finally, we examined ultrasound-induced membrane disrup-
tion in different cell types using the 0.5X microbubble condition 
and the 16% PEG 35,000 kDa/16% DEX 10,000 kDa system. 
Of the fi ve cell types we tested, (HUVEC, NIH3T3, MDA 231, 
HeLa and HUVEC/NIH3T3/MDA231 co-cultures), HUVECs 
were most sensitive to membrane disruption, while the overall 
level of cell death was similar among all other cell types 
(Figure  3 D). These results were expected because HUVECs, 
as with other types of primary cells, are typically more sensi-
tive to physical or chemical disruption than immortalized cell 
lines and cancer cells. Cell death was less than 5% in control 
regions without microbubbles for all of the cell types we tested. 
Time lapse imaging of the ultrasound treated microbubble sites 
revealed that dead cells remained in place after treatment. Over 
the course of 48 h, surviving cells from the treated regions and 
healthy cells from the surrounding regions frequently inter-
rogated the dead cells (Figure  3 E, Supporting Information 
Video 1), eventually displacing the dead cells through active 
removal of cell debris, migration and proliferation. 424 wileyonlinelibrary.com © 2013 WILEY-VCH Verlag G 2.3. Platforms for Testing Cell Physiology: Apoptosis 
 Most platforms for wound healing research involve either phys-
ical damage/displacement or chemical ablation that completely 
removes the cells. [ 28–31 ] In these assays, it is possible to quantify 
cell migration into cleared regions and secondary damage in the 
surrounding regions. However, many types of injuries in vivo 
do not result in complete removal of cells from the tissue all 
at once. Rather, cells undergo a more complex removal process 
where they die from direct trauma (necrosis) or initiate their 
own death in response to unfavorable environmental factors 
(apoptosis) and must then be cleared by immune cells in the sur-
rounding tissue. Thus, a physiological model for tissue damage 
should involve both necrotic and apoptotic modes of cell death, 
where the damaged/dying cells remain in place throughout the 
process. As demonstrated by the results presented in Figure  3 E 
and Supporting Information Video 1, ultrasound excitation of 
patterned microbubbles can effectively generate cells death in 
targeted regions without removal of cells. Patterning microbub-
bles to control the location of this injury provides an ideal plat-
form for investigating the physiology of the damaged cells and 
surrounding healthy regions. mbH & Co. KGaA, Weinheim Adv. Funct. Mater. 2013, 23, 3420–3431
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 Figure  4 .  Effects of ultrasound excitation of microbubbles on HUVECs. A) Treated cells displayed a variety of apoptotic morphologies. Red signal cor-
responds to PI nuclear staining and green signal corresponds to annexinV staining. B) Ultrasound activation with low pressure (e.g.,  < 0.3 MPa) for 
a long treatment duration resulted in a low percentage of cells dying from apoptosis. C) Short ultrasound pulses at high pressure amplitudes (e.g., 
0.4 MPa and 0.6 MPa) resulted in signifi cantly higher percentages of cells dying from apoptosis. Bars in (B,C) denote mean  ± SEM for n > 3 independent 
experiments. Scale bars  ∼ 20  μ m. 
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Low Intensity, Long Duration Therefore, we next investigated the mechanism of sonopo-
ration induced cell death. Using patterned microbubbles, we 
induced cell death in well-defi ned regions of the cell culture and 
stained with annexinV (to assay the appearance of phosphati-
dylserine on the cell surface) and PI (applied after ultrasound, 
to indicate loss of membrane integrity) (Figure  1 I,  Figure  4 A). 
The annexinV-positive cells displayed a variety of morphologies 
indicative of apoptosis including changes in membrane appear-
ance (roughening/ruffl ing), appearance of vacuoles and blebs 
and changes in nuclear morphology [ 32 , 33 ] (Figure  4 A). We tested 
the effects of two ultrasound regimes on cell apoptosis in our 
system. The fi rst regime consisted of a low pressure ultrasound 
treatment over a long period (30 s) (Figure  4 B). This treatment 
resulted in a low rate of acute apoptotic cell death, reaching a 
maximum of  ∼ 20% at 0.1 MPa as determined by PI/annexinV 
labeling. The second regime consisted of a high pressure, short 
(8  μ s) pulse of ultrasound (Figure  4 C). This treatment increased 
apoptotic cell death to  ∼ 70% at 0.6 MPa. 
 In contrast to other forms of apoptosis, our treated cells were 
immediately positive for both the apoptosis marker annexinV 
and the secondary necrosis marker PI, with both markers gen-
erally localized to the same cells. This staining pattern may be 
due to the ability of microbubbles to simultaneously disrupt 
the plasma membrane and initiate apoptosis, as early apoptotic 
cells without membrane disruption would normally exclude PI. 
We hypothesized that apoptosis was initiated by an infl ux of 
extracellular calcium through ultrasound-induced membrane © 2013 WILEY-VCH Verlag GAdv. Funct. Mater. 2013, 23, 3420–3431disruptions. We tested the effects of the levels of extracellular 
calcium on loss of cell viability/apoptosis in regions exposed 
to ultrasound treatment ( Figure  5 A–D). Higher acoustic pres-
sure (0.6 MPa) resulted in a higher percentage of cells labeled 
with PI and annexinV, as compared to lower acoustic pressure 
(0.3 MPa) (Figure  5 A,B). This could be due to the fact that at 
higher acoustic pressures, more microbubbles were excited 
to initiate necrosis and apoptosis in more cells than at lower 
acoustic pressures. This is because smaller microbubbles usu-
ally require a higher acoustic pressure for cavitation to occur. 
 The extracellular calcium concentration had an important 
impact on both the percentage of PI positive cells and the 
percentage of annexinV positive cells. The percentage of dead 
cells (both PI- and annexinV-labeled) was markedly higher 
when the extracellular calcium concentration was increased to 
more than 5 mM, indicating the existence of a threshold for 
extracellular calcium above which there is an increase in the 
percentage of apoptotic cells. Interestingly, at lower calcium 
concentrations ( ≤ 2 mM) and at 0.6 MPa ultrasound pressure, 
the percentage of PI-positive cells ( ∼ 60–65%) (Figure  5 A) was 
greater than the percentage of annexinV-positive cells ( ∼ 40–
45%) (Figure  5 B). This indicates that there is a pool of cells 
that die directly from microbubble trauma (acute cell death) 
without initiating apoptosis. This trend was also observed at 
lower ultrasound pressures (0.3 MPa), where the percentage 
of PI-positive cells ( ∼ 20–38%) was greater than the percentage 
of annexinV-positive cells ( ∼ 12%). However, at high enough 3425wileyonlinelibrary.commbH & Co. KGaA, Weinheim
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 Figure  5 .  Effects of extracellular calcium concentration on apoptosis in microbubble patterned cultures. PI labeling of dead cells (A) and annexinV 
labeling of apoptotic cells (B) increased in the presence of high extracellular calcium ( ≥ 5mM). Solid lines represent 0.3 MPa ultrasound pressure, 
dashed lines represent 0.6 MPa ultrasound pressure and black lines represent no ultrasound treatment. Bars denote mean  ± SEM for n > 3 independent 
experiments. C) Representative images of sonoporated cells in the presence of Cytomix buffer (no free extracellular calcium) for various ultrasound 
conditions. D) Representative image of sonoporated cells in the presence of 5 mM calcium buffer for various ultrasound conditions. (E) Fura-2AM 
ratiometric calcium imaging of HUVECs treated with either 0 or 5 mM calcium and either 0.3 or 0.6 MPa ultrasound pressure, along with representative 
images taken at frame 45 of imaging (shortly after the ultrasound pulse). Bars denote mean  ± SEM. F) JC1 staining for control (no ultrasound) and 
ultrasound-treated cells. Red staining indicates normal mitochondrial membrane potential and green staining indicates loss of membrane potential. 
G) Cell Event caspase staining for control (no ultrasound) and ultrasound-treated cells. Green nuclear staining indicates the activation of caspase in 
cells. All scale bars  ∼ 40  μ m. 
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that were PI-positive were also annexinV-positive, suggesting 
either that increased extracellular calcium helped to reduce the 
number of cells with acute necrotic death, possibly by facili-
tating membrane repair for some cells, in accordance with 6 wileyonlinelibrary.com © 2013 WILEY-VCH Verlag Gwhat has been observed in other studies, [ 34–36 ] or more likely, 
that elevated extracellular calcium concentration increased the 
number of cells undergoing apoptosis. This was true for both 
high and low pressure ultrasound conditions. Finally, at high 
calcium concentrations ( ≥ 5.0 mM), low ultrasound pressures mbH & Co. KGaA, Weinheim Adv. Funct. Mater. 2013, 23, 3420–3431
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pressures (0.6 MPa, 8  μ s) at killing cells. 
 We performed ratiometric calcium imaging using Fura-2AM 
to confi rm that calcium entered the cells as a result of micro-
bubble excitation (Figure  5 E). In the presence of extracellular 
calcium, there was a dramatic increase in the 340/380 nm ratio 
(corresponding to intracellular calcium concentration) that was 
observed immediately after the onset of ultrasound applica-
tion, indicating that calcium was entering the cells driven by 
its concentration gradient. One consequence of rapid calcium 
infl ux is a loss of mitochondrial membrane potential, followed 
by further release of calcium from intracellular mitochondrial 
and endoplasmic reticulum stores, leading to propagation of 
intracellular pro-apoptotic signals. [ 37 ] We confi rmed that this 
occurred in the cells within the microbubble patterned regions 
by applying the JC1 ratiometric stain for mitochondrial mem-
brane potential (Figure  5 F). An increased level of green signal 
in the mitochondria indicated that mitochondrial function was 
disrupted by ultrasound induced calcium entry. Finally, to prove 
that cells entered the late stages of apoptosis, we assayed caspase 
activity using the Cell Event apoptosis detection kit (Figure  5 G). 
Several hours after ultrasound treatment, almost every cell dis-
played a staining pattern indicative of caspase activity (cleavage 
of the Cell Event dye which subsequently labeled the nucleus). 
These results suggest a model whereby ultrasound excitation 
of microbubbles in the presence of high extracellular calcium 
leads to cell death that is almost exclusively apoptotic in nature. 
Our data also suggests that apoptosis is most likely mediated 
by infl ux of calcium into the cells which triggers the apoptosis 
cascade. Cells are unable to survive as this cascade initiates, 
resulting in simultaneous loss of membrane integrity with 
onset of apoptosis. 
 3. Discussion 
 We developed a new method for patterning microbubbles for 
controlled ultrasound-mediated cell membrane disruption 
(i.e., sonoporation). Our approach is easy to perform, can be 
applied to cells growing on a variety of substrates and offers 
the ability to apply multiplexed ultrasound/microbubble treat-
ments to a small number of cells. We tested two types of 
commercially available microbubbles and found that strepta-
vidin-coated (Targestar-SA) microbubbles performed better 
within our system. Although both Defi nity and Targestar-SA 
microbubbles possess a perfl uorocarbon gas core bounded by 
a lipid shell, the difference in partitioning can be explained 
by the fact that the streptavidin on the surface of Targestar-SA 
microbubbles partitions to dextran. The ability to spatially pat-
tern microbubbles enabled controlled and effective ultrasound 
treatment of cells. We demonstrated that patterning of micro-
bubbles can be used to disrupt cell membranes of various cell 
types within defi ned regions, allowing intracellular entry of 
otherwise cell impermeant agents such as PI. The targeted 
areas could be monitored over several days to observe the cell 
responses in the damaged regions. We also demonstrated that 
the patterned microbubbles selectively induced apoptosis in 
subpopulations of cells following ultrasound treatment. This 
is relevant for researchers interested in apoptosis and useful © 2013 WILEY-VCH Verlag GAdv. Funct. Mater. 2013, 23, 3420–3431as a testing platform for ultrasound/microbubble tissue 
disruption. 
 3.1. Patterning of Microbubbles with ATPS 
 Patterning techniques are frequently used in biomedical 
research for performing cell co-cultures, migration assays, 
wound healing assays, therapeutic targeting experiments and 
high throughput analyses. A variety of approaches have been 
developed for controlling placement of cells, including selective 
patterning of substrate materials, [ 38 , 39 ] and direct cell printing 
with inkjets, stencils and more recently ATPSs. [ 7 , 9 , 40–43 ] These 
technologies are useful for spatially organizing cells, but 
some cell types require patterning in situ (i.e., they are already 
growing on a surface). This is often the case for primary cells 
that have strict substrate requirements and a limited potential 
to divide in vitro. There are relatively few technologies that 
permit patterning on cells already growing as monolayers. 
ATPS micropatterning is capable of this type of patterning due 
to its biomolecule and particle partitioning ability. [ 6 , 8 ] Here, we 
demonstrated that ATPSs can be used to deliver microbubbles 
to preformed monolayers of cells. 
 Physical disruption of the plasma membrane can be achieved 
by microinjection, hydrodynamic delivery, magnetotransfection, 
laser poration, ballistic delivery and electroporation, in addition 
to sonoporation. [ 44–47 ] Among these methods, electroporation 
and sonoporation are two of the most effective physical methods 
for disrupting membrane integrity. [ 48–51 ] However, neither tech-
nique is traditionally amenable to patterning. We demonstrated 
that spatial patterning of sonoporation could be achieved using 
ATPSs to confi ne microbubbles, which are known to be highly 
effective sonoporation facilitators. 
 Our ATPS microbubble patterning strategy provides several 
advantages for sonoporation. First, it provides an easy way to 
precisely place microbubbles in close vicinity to cells, thereby 
providing a controlled sonoporation platform. In our system, 
the microbubbles reside directly above the cells and are well 
dispersed in the XY dimensions, as confi rmed by brightfi eld 
microscopy and our observations that microbubbles are in 
nearly the same focal plane as cells. This allowed us to over-
come one of the main challenges in sonoporation research, the 
inherent unpredictability associated with free-fl oating micro-
bubbles and controlling their impact on cells. Conventionally, 
sonoporation experiments have been conducted in centrifuge 
tubes or Petri dishes, where microbubbles are freely fl oating in 
the bulk solution. [ 52–55 ] In these systems, the relative locations 
of the microbubbles and the cells are random and cannot be 
controlled. In some sonoporation experiments, cells are cul-
tured inside thin chambers (e.g., Opticell). To ensure micro-
bubbles are in contact with the cultured cells, these thin cham-
bers are positioned upside down so that microbubbles fl oat up 
to the adherent cells. [ 56–58 ] However, this approach often leads 
to clustering of microbubbles at the boundaries of cells due to 
differences in the height of cells across the cell monolayer. In 
these systems, it is diffi cult, if not entirely impossible, to target 
a small region or sub-population of cells. 
 In our approach, the microbubbles can be easily positioned 
on any target cell population at controlled spatial locations. In 3427wileyonlinelibrary.commbH & Co. KGaA, Weinheim
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ment durations are used to maximize the chance of free-fl oating 
microbubbles impacting the cells. Since our approach mini-
mizes free-fl oating microbubbles, we used short (microsecond) 
ultrasound durations; therefore, the microbubble dynamics are 
better controlled without large translational movements due to 
effects such as microstreaming. 
 Our system can be used for cells that grow on virtually any 
substrate, making this approach more versatile and adaptable. 
The ATPS medium itself imposes no acoustic discontinuity 
above the cells while confi ning the bubbles within a fl uid (this is 
problematic for most microdevices). In addition, our approach 
reduces the amount of reagent and the number of microbub-
bles by as much as 10 000-fold because microbubbles are con-
fi ned in 0.1  μ L DEX droplets instead of 10 mL solutions used 
in conventional sonoporation experiments in a dish or similar 
container. Since we use small amounts of microbubbles and can 
generate well defi ned patterns, this approach is highly amenable 
to multiplexing ultrasound parameters, the microbubble type/
concentration, and the concentration and type of biomolecule 
present in the extracellular space. The fi nal advantage of our 
system relates to the need for antibody/microbubble conjuga-
tion. For targeted microbubble applications, antibody conjuga-
tion is needed to ensure microbubble targeting and attachment 
to the cell surface. Our approach does not require antibodies 
for targeting cells because the DEX droplets confi ne the micro-
bubbles at the cell surface. This allows the same microbubbles 
to be used with any cell type without any modifi cation. 
 3.2. Implications for Apoptosis Research 
 Ultrasound-excited microbubbles that are capable of gener-
ating signifi cant physical impact on cells at the micro- and 
nano-scales provide a unique tool for manipulation of cells. 
Patterning of microbubbles using ATPSs provides a novel 
system with great potential for new applications. In this study, 
we demonstrated a novel application of ATPS microbubble pat-
terning for selectively inducing apoptosis. A number of studies 
have shown sonoporation induced apoptosis in cells, [ 52 , 59–61 ] 
although the mechanisms are not completely understood. 
Moreover, in sonoporation-mediated gene delivery experi-
ments, a large number of cells are often damaged or killed by 
ultrasound-activated microbubbles, although the number of 
dead cells and the mechanism of their death (i.e., apoptosis vs 
necrosis) are not always clearly reported in the literature. In 
our study, the spatial localization and patterning of microbub-
bles using ATPS enabled detailed investigation of ultrasound 
excitation of microbubbles and their effects on the cells. With 
ATPS microbubble patterning, we induced a high proportion 
of cells to enter apoptosis in targeted areas within a monolayer 
by inducing calcium infl ux into the cells during sonoporation. 
Based on our previous experiments using DEX as a delivery 
vehicle for lipofection agents, the DEX and PEG polymers 
have little to no effect on cell viability. Therefore, apoptosis was 
mediated by microbubble-induced membrane damage and cal-
cium infl ux, as evidenced by a dose response to extracellular 
calcium. This example illustrates that our technology of ATPS 
microbubble patterning may be used as a potential platform for 8 wileyonlinelibrary.com © 2013 WILEY-VCH Verlag Gwww.MaterialsViews.com
studying apoptosis through transmembrane delivery of ionic 
or chemical initiators of apoptosis. Since our technique facili-
tates multiplexing of both microbubble condition and ultra-
sound treatment for testing the effects of sonoporation on cell 
viability, this may be useful for studying localized cell injury or 
apoptosis, while testing a wide range of treatments or acquiring 
a large number of independent observations. [ 62 , 63 ] 
 Apoptotic cells are recognized and removed by resident mac-
rophages in tissue; whereas damage caused by necrotic injury is 
not recognized by the immune system and can lead to toxicity 
in the surrounding tissue. [ 64 ] Since apoptosis is highly localized 
to specifi c cell populations in our system, ATPS microbubble 
patterning for ultrasound excitation may serve as a useful 
test system for investigating the interactions of apoptotic cells 
with surrounding cells, including the ability of healthy cells to 
migrate into apoptotic regions and remove debris. The effect 
that dying cells have on neighboring healthy populations can 
also be readily investigated in our system. Furthermore, by 
using ATPS and microbubbles to locally kill cells it will be pos-
sible to perform well controlled wound healing assays without 
physical removal of the damaged region. In our system, the 
wounded region consisting of both apoptotic and necrotic cells 
may represent a more physiologically relevant in vitro model 
for wound healing. 
 3.3. Future Directions 
 It will be useful to design easier to use setups to dispense the 
DEX droplets and apply ultrasound excitation to microbub-
bles. Development of new microbubbles that partition better 
in DEX can also help to improve and expand this technology. 
Finally, our technology may serve as a useful high throughput 
testing platform to investigate the mechanisms for various 
microbubble-potentiated ultrasound applications such as ultra-
sound mediated drug delivery for cancer treatment, [ 65 ] as well 
as ultrasound tissue ablation, where fractionation, necrosis and 
enhanced apoptosis have been identifi ed as factors benefi cial 
for treatment. [ 66–68 ] 
 4. Experimental Section 
 ATPS Formulation : ATPSs were formulated from DEX (ranging in 
molecular weight from 3500 kDa to 500 000 kDa; Pharmacosmos, 
Denmark) and PEG 35 000 kDa (Sigma, St. Louis, MO). These polymers 
were reconstituted as aqueous solutions in various buffered media. 
The initial formulations tested were near critical point concentrations 
of 9% DEX 3500 kDa/10% PEG 35 000 kDa, 7% DEX 10 000 kDa/7% 
PEG 35 000 kDa, and 3.2% DEX 500 000 kDa/2.5% PEG 35 000 kDa in 
their fully equilibrated forms. For experiments that required additional 
reagents in the ATPS solutions, concentrations slightly higher than 
the critical points were used (e.g., stock solutions of 16% DEX 10 000 
kDa/16% PEG 35 000 kDa, corresponding to a solution of approximately 
8% DEX 10 000 kDa/8% PEG 35 000 kDa after full equilibration. ATPSs 
formed from stock solutions of 8% DEX 10 000 kDa/16% PEG 35 000 
kDa and 4% DEX 10 000 kDa/16% PEG 35 000 kDa were also tested. 
 Microbubble Partitioning : Two types of commercially available 
ultrasound contrast agent microbubbles were used in this study: 
Defi nity (Lantheus Medical Imaging, Billerca, MA) and Targestar-SA 
(Targeson, San Diego, CA). Defi nity microbubbles are composed of mbH & Co. KGaA, Weinheim Adv. Funct. Mater. 2013, 23, 3420–3431
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a perfl uorocarbon microsphere, encapsulated with a lipid shell coated 
with streptavidin, which permits biotinylated ligands to bind to its 
surface via biotin-streptavidin conjugation chemistry. The affi nities 
of different microbubbles for the above phase systems were tested by 
mixing stock solutions of microbubbles in equal concentrations of 
twice-concentrated solutions of PEG and DEX in a microcentrifuge tube. 
The phase systems were then allowed to separate by gravity at room 
temperature. Once the phase systems reached equilibrium ( ∼ 10 min), 
samples were taken from the top (PEG) and bottom (DEX) phases along 
with the PEG/DEX interface and diluted below the critical point (1:10 in 
PBS) to remove any residual PEG/DEX droplets that could be mistaken 
for microbubbles. Microbubbles were placed on a hemocytometer and 
imaged under brightfi eld illumination using a 10x objective. Images were 
imported into imageJ and numbers of microbubbles were automatically 
quantifi ed using the automated nuclei counting plugin (Center for Bio-
Image Informatics, UCSB). Partitioning was measured for Defi nity lipid 
coated microbubbles, Targestar-SA microbubbles (without antibody) and 
Targestar-SA microbubbles conjugated to biotinylated IgG by counting 
the numbers of microbubbles in each phase. Partitioning was also 
investigated by placing the microbubbles within non-equilibrated twice-
concentrated solutions of DEX which were then deposited into PEG as 
1  μ L droplets. The movement of microbubbles within the DEX droplets 
was monitored using video microscopy. 
 Cell Culture : Human umbilical vein endothelial cell (HUVEC) 
preparations (passage number 3-7) were plated one day prior to the 
experiment onto tissue culture treated 35 mm 2 glass bottom dishes. 
NIH3T3, MDA231 and HeLa cells were cultured under standard 
conditions and then either seeded separately or as mixtures (co-cultures) 
in HUVEC medium in 35 mm 2 glass bottom dishes one day prior to the 
experiment. A seeding density of 200 cells/mm 2 was used to ensure 
 ∼ 80% confl uence the following day. Cultures were maintained in a 
humidifi ed incubator at 37 ° C, with 5% CO 2 . For experimental treatments, 
cultures were removed from the incubator, covered with a solution of 
16% PEG, patterned with DEX/microbubbles and immediately treated 
by ultrasound. After 10 min incubation, the ATPS was removed through 
3–5 consecutive washes in PBS. The cells were then either reintroduced 
to culture medium and returned to standard incubation conditions for 
later analysis or immediately stained and imaged. 
 Microbubble Preparation and ATPS Micropatterning : Microbubbles 
( ∼ 1  × 10 9 particles per mL) were incorporated into the DEX phase by 
mixing a solution of 32% DEX 10 000 kDa with an equal volume of 
microbubbles to obtain a solution of  ∼ 0.5  × 10 9 microbubbles/mL 
in 16% DEX, representing the optimal microbubble concentration. 
Solutions with 10-fold and 100-fold lower microbubble concentrations 
were also tested. The microbubble solutions were loaded into capillary 
needles that were positioned above the PEG coated cells. Capillary tips 
were lowered into the PEG and droplets of DEX containing microbubbles 
( ∼ 0.05–0.1  μ L in volume) were dispensed in the desired patterns above 
the cells. These droplets sank vertically in the PEG solution, where they 
came into contact with the cells and spread on the cell monolayer. Once 
the fi nal droplet was in place, the micropatterned cultures were ready for 
ultrasound exposure. 
 Experimental Setup for Ultrasound Application : The experimental 
setup consisted of a microscope equipped with a non-focused circular 
ultrasound transducer (center frequency 1.25 MHz, active element 
diameter 0.6 cm) (Advanced Devices, Wakefi eld, MA, USA) that was 
driven by a function generator (33250A, Agilent Technologies, Palo Alto, 
CA, USA) and an amplifi er (75A250, Amplifi er Research, Souderton, 
PA, USA). The transducer was calibrated in free fi eld in water using a 
calibrated 40  μ m needle hydrophone (HPM04/1, Precision Acoustics, 
Dorchester, UK). The transducer was positioned at 45 degrees (to avoid 
standing wave buildup and accommodate simultaneous microscopic 
imaging) with its active surface  ∼ 7.5 mm (Rayleigh distance) from the 
cell culture surface such that the maximum ultrasonic pressure was 
focused on the cells. This confi guration allowed us to simultaneously 
apply ultrasound and microscopically observe microbubbles. Ultrasound 
excitation of microbubbles was monitored by a high speed camera © 2013 WILEY-VCH Verlag GAdv. Funct. Mater. 2013, 23, 3420–3431(Photron FASTCAM SA1, San Diego, CA) at a frame rate of 20 000 frames 
s  − 1 . A cooled CCD camera (Photometrics QuantEM, Tucson, AZ, USA), 
a monochromator with 5 nm bandpass (DeltaRAM X, PTI, Birmingham, 
NJ, USA) and a polychroic fi lter (73000v2, Chroma, Rockingham, VT, 
USA) were used to perform ratiometric epifl uorescence and standard 
epifl uorescence imaging of molecules delivered by sonoporation. The 
ultrasound treatments were applied either as single 8  μ sec pulses or as 
continuous (30 s) wave forms that varied in peak acoustic pressure from 
0.05 MPa to 0.6 MPa. 
 Apoptosis and Calcium Infl ux : To investigate whether calcium infl ux 
during sonoporation plays a role in sonoporation triggered apoptosis 
in our system, we used PEG solutions containing various calcium 
concentrations either in a buffer designed to mimic the intracellular 
ion concentration of cells (Cytomix) [ 69 ] or in PBS/DPBS. Calcium 
concentrations ranged from 0 to 20 mM. 
 Cells were exposed to either 0.3 or 0.6 MPa peak acoustic pressures 
and allowed to recover for 15 min at room temperature before washing 
in PBS. Cells were then washed in annexinV binding buffer and 
incubated with a solution containing Alexa 488-annexinV (Invitrogen) 
and PI to detect apoptosis. Regions with microbubbles were compared 
to regions without microbubbles and the total number of PI-positive and 
annexinV-positive cells was quantifi ed as before for each condition, with 
the exception that PI was added after ultrasound treatment and used as 
a dead cell marker. Ratiometric imaging using Fura-2 AM (Invitrogen) 
was used to confi rm that changes in intracellular calcium had occurred 
following ultrasound treatment. For ratiometric calcium imaging, cells 
were loaded with Fura2-AM before ultrasound by incubating the cells 
with Fura2-AM and Pluronic F-127 (0.05% v/v of 10% w/v) for 60 min 
at 37  ° C. The cells were then washed 3 times to remove extracellular 
Fura-2AM. [ 70 ] To quantify intracellular calcium concentration following 
ultrasound, the ratio of signal at 340/380 nm was calculated for each 
treated cell. 
 Viability Assays : To analyze cell viability as a function of ultrasound/
calcium-induced apoptosis, we used several independent tests. PI 
staining, applied after ultrasound treatment, revealed cells that were 
not able to reseal their membranes after sonoporation, while annexinV 
labeling was used as an early stage marker for apoptosis. Phase contrast 
images were used to quantify the total number of cells in each image 
and the percentage of annexinV- and PI-positive cells was calculated 
for various ultrasound and calcium conditions. Phase contrast and PI 
images also allowed us to qualitatively inspect the status of cells in terms 
of general morphology, membrane features and nuclear morphology. JC1 
ratiometric staining (Invitrogen) was used to confi rm that mitochondrial 
membrane potential was disrupted in the apoptotic cells. Cell Event 
caspase stain (Invitrogen) was used to confi rm that cells entered the late 
stages of apoptosis. 
 Data Analysis : Image J and MetaFluor Analyst (Molecular Devices, 
Downingtown, PA, USA) photometric software were used for image 
analysis. Mosaic and live cell images were captured, compiled and 
stitched using Zeiss Axiovision software. Statistical analyses were carried 
out using Sigmaplot with Sigmastat. All graphs are presented as mean 
values  ± standard error of the mean. 
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 Supporting Information is available from the Wiley Online Library or 
from the author. 
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